Eps Summary of argenx SE

argenx SE's latest annual eps in 2023 was -5.16 USD , up 60.46% from previous year.
argenx SE's latest quarterly eps in 2024 Q1 was -1.04 USD , up 38.82% from previous quarter.
argenx SE reported an annual eps of -13.05 USD in 2022, down -63.33% from previous year.
argenx SE reported an annual eps of -7.99 USD in 2021, up 44.24% from previous year.
argenx SE reported a quarterly eps of -1.04 USD for 2024 Q1, up 38.82% from previous quarter.
argenx SE reported a quarterly eps of -0.52 USD for 2023 Q1, up 25.71% from previous quarter.

Annual Eps Chart of argenx SE (2023 - 2011)

Historical Annual Eps of argenx SE (2023 - 2011)

Year	Eps	Eps Growth
2023	-5.16 USD	60.46%
2022	-13.05 USD	-63.33%
2021	-7.99 USD	44.24%
2020	-14.33 EUR	-202.96%
2019	-4.73 EUR	-123.11%
2018	-2.12 EUR	-54.74%
2017	-1.37 EUR	-15.13%
2016	-1.19 EUR	-12.26%
2015	-1.06 EUR	36.14%
2014	-1.66 EUR	-207.41%
2013	-0.54 EUR	34.15%
2012	-0.82 EUR	-182.76%
2011	-0.29 EUR	0.0%

Year	Eps	Eps Growth
2024 Q2	-0.55 USD	47.12%
2024 Q1	-1.04 USD	38.82%
2023 Q1	-0.52 USD	25.71%
2023 Q2	-1.69 USD	-225.0%
2023 FY	- USD	60.46%
2023 Q4	-1.70 USD	-36.0%
2023 Q3	-1.25 USD	26.04%
2022 Q4	-0.70 USD	83.57%
2022 Q2	-4.01 USD	8.03%
2022 Q1	-4.36 USD	5.63%
2022 Q3	-4.26 USD	-6.23%
2022 FY	- USD	-63.33%
2021 FY	- USD	44.24%
2021 Q1	-0.81 EUR	-113.37%
2021 Q2	2.07 USD	355.56%
2021 Q3	-4.54 USD	-319.32%
2021 Q4	-4.62 USD	-1.76%
2020 Q4	6.06 USD	291.77%
2020 Q3	-3.16 EUR	0.0%
2020 FY	- EUR	-202.96%
2019 FY	- EUR	-123.11%
2019 Q1	0.20 EUR	122.22%
2019 Q2	-1.57 EUR	-885.0%
2019 Q3	-0.67 EUR	57.32%
2019 Q4	-2.48 EUR	-270.15%
2018 Q4	-0.90 EUR	-76.47%
2018 Q2	-0.04 EUR	94.25%
2018 Q1	-0.67 EUR	-48.89%
2018 FY	- EUR	-54.74%
2018 Q3	-0.51 EUR	-1224.68%
2017 Q1	-0.35 EUR	-9.37%
2017 FY	- EUR	-15.13%
2017 Q4	-0.45 EUR	-45.16%
2017 Q3	-0.31 EUR	-2483.33%
2017 Q2	-0.01 EUR	96.57%
2016 Q4	-0.32 EUR	-39.13%
2016 FY	- EUR	-12.26%
2016 Q3	-0.23 EUR	-21.05%
2016 Q2	-0.19 EUR	9.52%
2016 Q1	-0.21 EUR	38.24%
2015 FY	- EUR	36.14%
2015 Q4	-0.34 EUR	-54.55%
2015 Q3	-0.22 EUR	26.67%
2015 Q2	-0.30 EUR	-42.86%
2015 Q1	-0.21 EUR	27.59%
2014 FY	- EUR	-207.41%
2014 Q4	-0.29 EUR	-163.64%
2014 Q2	-0.23 EUR	-43.75%
2014 Q1	-0.16 EUR	-23.08%
2014 Q3	-0.11 EUR	52.17%
2013 Q3	-0.01 EUR	97.4%
2013 Q2	-0.25 EUR	-66.67%
2013 Q4	-0.13 EUR	-1900.0%
2013 FY	- EUR	34.15%
2013 Q1	-0.15 EUR	0.0%
2012 FY	- EUR	-182.76%
2011 FY	- EUR	0.0%

Peer Eps Comparison of argenx SE

Name	Eps	Eps Difference
Burzynski Research Institute, Inc.	-0.01 USD	-50488.235%
Arch Therapeutics, Inc.	-2.27 USD	-127.313%
Evofem Biosciences, Inc.	10.35 USD	149.855%
Nascent Biotech, Inc.	-0.01 USD	-38407.463%
Rebus Holdings, Inc.	-0.03 USD	-15974.766%
Santhera Pharmaceuticals Holding AG	5.95 USD	186.723%
Qrons Inc.	-0.06 USD	-8750.772%
Adynxx, Inc.	- USD	Infinity%
Neon Bloom, Inc.	-0.00 USD	-343900.0%
Northwest Biotherapeutics, Inc.	-0.06 USD	-8873.913%
ProtoKinetix, Incorporated	-0.01 USD	-51500.0%
Skye Bioscience, Inc.	-5.37 USD	3.911%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	89.839%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	-9919.417%
SQZ Biotechnologies Company	-2.76 USD	-86.957%
Intellipharmaceutics International Inc.	-0.09 USD	-5803.89%
Propanc Biopharma, Inc.	-0.02 USD	-21672.152%
Mesoblast Limited	-0.09 USD	-5691.246%
Marizyme, Inc.	-1.44 USD	-258.333%
Genus plc	0.12 USD	4400.0%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	-121.459%
Pharming Group N.V.	-0.02 USD	-31949.689%
Therapeutic Solutions International, Inc.	-0.00 USD	-737042.857%
CNBX Pharmaceuticals Inc.	-0.42 USD	-1128.571%
Nymox Pharmaceutical Corporation	-0.10 USD	-5247.15%
ContraFect Corporation	-124.97 USD	95.871%
PsyBio Therapeutics Corp.	-0.04 USD	-12185.714%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	-42900.0%
IMV Inc.	-4.37 USD	-18.078%
AXIM Biotechnologies, Inc.	-0.04 USD	-14476.271%
MultiCell Technologies, Inc.	-0.00 USD	-5159900.0%
ONE Bio Corp.	1.43 USD	460.839%
Accustem Sciences Inc.	-0.34 USD	-1417.647%
RVL Pharmaceuticals plc	-0.58 USD	-789.655%
Arno Therapeutics, Inc.	- USD	Infinity%
EV Biologics, Inc.	-0.12 USD	-4200.0%
Q BioMed Inc.	-0.08 USD	-6506.914%
Emmaus Life Sciences, Inc.	-0.07 USD	-7239.972%
Mosaic ImmunoEngineering Inc.	-0.33 USD	-1463.636%
Biomind Labs Inc.	-0.02 USD	-31751.852%
American Oriental Bioengineering, Inc.	-781.24 USD	99.34%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-69629.73%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Oncotelic Therapeutics, Inc.	-0.02 USD	-25829.648%
GlobeStar Therapeutics Corporation	-0.00 USD	-214900.0%
THC Farmaceuticals, Inc.	-0.00 USD	-644900.0%
Acro Biomedical Co., Ltd.	-0.26 USD	-1884.615%
Curative Biotechnology, Inc.	-0.01 USD	-58536.364%
GB Sciences, Inc.	-0.00 USD	-125753.659%
Alpha Cognition Inc.	-0.15 USD	-3340.0%
HST Global, Inc.	-0.03 USD	-18394.624%
CSL Limited	2.73 USD	289.011%
Wesana Health Holdings Inc.	-0.05 USD	-10199.401%
Halberd Corporation	-0.00 USD	-5159900.0%
Enzolytics Inc.	-0.00 USD	-737042.857%
Agentix Corp.	-0.04 USD	-14642.857%
Resverlogix Corp.	-0.01 USD	-36238.028%
Nuo Therapeutics, Inc.	-0.08 USD	-6743.501%
MetaStat, Inc.	- USD	Infinity%
Enzon Pharmaceuticals, Inc.	0.00 USD	397023.077%
Endonovo Therapeutics, Inc.	0.03 USD	20657.769%
RespireRx Pharmaceuticals Inc.	-0.04 USD	-14353.782%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	-25700.0%
AVAX Technologies, Inc.	-0.05 USD	-9473.284%
Zenith Capital Corp.	-0.07 USD	-7281.974%
Genscript Biotech Corporation	-0.05 USD	-11265.639%
Ember Therapeutics, Inc.	-0.01 USD	-81804.762%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	-36.87%
WPD Pharmaceuticals Inc.	-0.00 USD	-1031900.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	-5551.698%
Kadimastem Ltd	-0.78 USD	-561.538%
Helix BioMedix, Inc.	-4.70 USD	-9.787%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Capstone Therapeutics Corp.	-36.39 USD	85.82%
BioStem Technologies, Inc.	-0.62 USD	-732.258%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-43261.345%
LadRx Corporation	0.68 USD	858.824%
Cell Source, Inc.	-0.17 USD	-2935.294%
Regen BioPharma, Inc.	0.29 USD	1879.31%
Regen BioPharma, Inc.	0.26 USD	2084.615%
NovAccess Global Inc.	-0.23 USD	-2143.478%
Affymax, Inc.	-0.39 USD	-1223.077%
Itoco Inc.	-0.01 USD	-67794.737%
Rasna Therapeutics, Inc.	-0.01 USD	-51500.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-206300.0%
Mobile Lads Corp.	-0.01 USD	-92042.857%
CytoDyn Inc.	-0.05 USD	-9654.253%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	-1031900.0%
NanoSphere Health Sciences Inc.	-0.02 USD	-23143.243%
Alseres Pharmaceuticals, Inc.	-153.67 USD	96.642%
SYBLEU INC	-0.02 USD	-29385.714%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	-36238.028%
International Stem Cell Corporation	-0.02 USD	-31363.415%
Bioxytran, Inc.	-0.03 USD	-16075.549%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-5159900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	35.419%
Adhera Therapeutics, Inc.	-1.18 USD	-337.288%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	-15076.471%
Innovation Pharmaceuticals Inc.	-0.01 USD	-81804.762%
Neutra Corp.	-0.00 USD	-5159900.0%
Windtree Therapeutics, Inc.	-94.23 USD	94.524%
PureTech Health plc	-2.38 USD	-116.807%
Coeptis Therapeutics, Inc.	-0.83 USD	-521.687%
IXICO plc	-0.02 USD	-21047.541%
IntelGenx Technologies Corp.	-0.06 USD	-8984.507%
Gelesis Holdings, Inc.	-1.35 USD	-282.222%
CSL Limited	5.47 USD	194.333%
Cellectis S.A.	-1.77 USD	-191.525%

Global Stocks Search

argenx SE (ARGNF)

Eps Summary of argenx SE

Annual Eps Chart of argenx SE (2023 - 2011)

Historical Annual Eps of argenx SE (2023 - 2011)

Peer Eps Comparison of argenx SE